CDC advises updated COVID vaccine for everyone over 6 months of age
Jun 28, 2024
Americans 65 and older account for two-thirds of COVID hospitalizations and 82% of in-hospital deaths, yet only about 40% of Americans in that age group were immunized with the COVID vaccines that were...
A second booster dose resulted in 123,869 fewer hospitalizations and 5,524 fewer deaths versus a single-dose campaign.
No elevated risk for stroke seen after COVID-19 bivalent vaccine receipt
Mar 20, 2024
No evidence was seen for an increased risk for stroke in one- to 21-day or 22- to 42-day windows compared with a 43- to 90-day window after the vaccine.
Electronic nudge for flu vaccination does not improve clinical outcomes
Mar 19, 2024
No significant difference was seen in hospitalization for pneumonia or influenza or in hospitalization for any cause or mortality.
Updated immunization schedule presented for adults for 2024
Jan 11, 2024
The changes include a recommendation for all adults to receive a dose of the new COVID-19 vaccine and RSV vaccination.
Bivalent COVID-19 shot effective for preventing thromboembolic events
Jan 11, 2024
The findings were seen for adults aged 65 years and older and for those aged 18 years and older with end-stage renal disease.
Nobel Prize for medicine awarded to COVID-19 vaccine pioneers
Oct 02, 2023
The prize panel said that their discovery ‘fundamentally changed our understanding of how mRNA interacts with our immune system.’
CDC relaxes COVID-19 vaccination rules for foreign travelers
Apr 28, 2023
Another federal agency, the US Centers for Medicare & Medicaid Services, announced that healthcare workers would be considered “fully vaccinated” with the one bivalent dose.
RSVpreF safe, effective for preventing respiratory syncytial virus illness in seniors
Apr 10, 2023
The findings seen in phase 3 trial of adults aged 60 years and older receiving a single intramuscular injection of RSVpreF vaccine.
FDA panel backs second RSV vaccine for older Americans
Mar 02, 2023
In a two-part vote, the panel voted 10-to-2 in favor of the vaccine’s safety and unanimously on the shot’s effectiveness.